357 related articles for article (PubMed ID: 9053024)
1. [Nucleoside analogs inhibiting reverse transcriptase: use in adult patient with HIV infection].
Aguirrebengoa K; Mallolas J; Uriz J; Torres Tortosa M
Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():3-9. PubMed ID: 9053024
[No Abstract] [Full Text] [Related]
2. Drugs for HIV infection.
Med Lett Drugs Ther; 2000 Jan; 42(1069):1-6. PubMed ID: 10683666
[No Abstract] [Full Text] [Related]
3. What they say about nucleoside drugs.
Posit Aware; 1999; 10(1):28-34. PubMed ID: 11366520
[TBL] [Abstract][Full Text] [Related]
4. What they say about: nucleoside drugs.
Posit Aware; 2000; 11(1):37-43. PubMed ID: 11366349
[TBL] [Abstract][Full Text] [Related]
5. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
[TBL] [Abstract][Full Text] [Related]
6. Ongoing open-label trials of triple therapy with stavudine and lamivudine or stavudine and didanosine plus nelfinavir.
Anderson RD
Antivir Ther; 1998; 3 Suppl 4():63-4. PubMed ID: 10723514
[TBL] [Abstract][Full Text] [Related]
7. Stavudine plus a non-thymidine nucleoside reverse transcriptase inhibitor as a backbone for highly active antiretroviral therapy.
Clumeck N
Antivir Ther; 1998; 3 Suppl 4():39-43. PubMed ID: 10723508
[TBL] [Abstract][Full Text] [Related]
8. Drugs for HIV infection.
Med Lett Drugs Ther; 1997 Dec; 39(1015):111-6. PubMed ID: 9402928
[No Abstract] [Full Text] [Related]
9. [Anti-HIV treatment, today and in the near future].
Danner SA; Lange JM; Cooper DA
Ned Tijdschr Geneeskd; 1992 Aug; 136(31):1496-500. PubMed ID: 1379700
[No Abstract] [Full Text] [Related]
10. [HIV-therapy: as early and as intensive as possible].
Dtsch Med Wochenschr; 1997 Oct; 122(41):A27. PubMed ID: 9378051
[No Abstract] [Full Text] [Related]
11. The ALBI trial: a randomized controlled trial comparing stavudine plus didanosine with zidovudine plus lamivudine and a regimen alternating both combinations in previously untreated patients infected with human immunodeficiency virus.
Molina JM; Chêne G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM
J Infect Dis; 1999 Aug; 180(2):351-8. PubMed ID: 10395849
[TBL] [Abstract][Full Text] [Related]
12. A randomized double-blind trial of the addition of lamivudine or matching placebo to current nucleoside analogue reverse transcriptase inhibitor therapy in HIV-infected children: the PENTA-4 trial. Paediatric European Network for Treatment of AIDS.
AIDS; 1998 Oct; 12(14):F151-60. PubMed ID: 9792371
[TBL] [Abstract][Full Text] [Related]
13. Comparison of genotypic and phenotypic resistance patterns of human immunodeficiency virus type 1 isolates from patients treated with stavudine and didanosine or zidovudine and lamivudine.
Picard V; Angelini E; Maillard A; Race E; Clavel F; Chêne G; Ferchal F; Molina JM
J Infect Dis; 2001 Sep; 184(6):781-4. PubMed ID: 11517441
[TBL] [Abstract][Full Text] [Related]
14. Update on nevirapine: quest for a niche.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1997 Sep; 3(9):37-43. PubMed ID: 11364713
[TBL] [Abstract][Full Text] [Related]
15. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699
[TBL] [Abstract][Full Text] [Related]
16. Guide to major clinical trials of antiretroviral therapy administered to patients infected with human immunodeficiency virus.
Spooner KM; Lane HC; Masur H
Clin Infect Dis; 1996 Jul; 23(1):15-27. PubMed ID: 8816123
[No Abstract] [Full Text] [Related]
17. Antiretrovirals.
Temesgen Z; Wright AJ
Mayo Clin Proc; 1999 Dec; 74(12):1284-301. PubMed ID: 10593358
[TBL] [Abstract][Full Text] [Related]
18. New nucleoside reverse transcriptase inhibitors for the treatment of HIV infections.
Otto MJ
Curr Opin Pharmacol; 2004 Oct; 4(5):431-6. PubMed ID: 15351346
[TBL] [Abstract][Full Text] [Related]
19. Therapy of HIV infections: problems and prospects.
Ho DD
Bull N Y Acad Med; 1996; 73(1):37-45. PubMed ID: 8804736
[No Abstract] [Full Text] [Related]
20. Predictive factors and selection of thymidine analogue mutations by nucleoside reverse transcriptase inhibitors according to initial regimen received.
Flandre P; Descamps D; Joly V; Meiffrédy V; Tamalet C; Izopet J; Aboulker JP; Brun-Vézinet F
Antivir Ther; 2003 Feb; 8(1):65-72. PubMed ID: 12713066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
